Chinese PLA General Hospital: Toxemia trials

The registry lists 14 Toxemia studies with Chinese PLA General Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Characteristics and Risk Factors for In-Hospital Mortality in Surgical Patients With Abdominal SepsisCompletedNCT06756750
• Value of Urine sTREM-1 on Early Predicting AKI in SepsisStatus unknownNCT02920736
• Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With SepsisCompletedNCT02180009
• Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome SequencingStatus unknownNCT01920217
• Amino Acids Expression Profiling of Patients With SepsisStatus unknownNCT01818830
• Sepsis MetabolomicsCompletedNCT01649440
• Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han PopulationStatus unknownNCT01504243
• Urinary Proteomics Analysis for Sepsis and PrognosisStatus unknownNCT01493492
• Serum Proteomics Analysis for SepsisStatus unknownNCT01493466
• MiRNAs Evaluate the Prognosis of Sepsis by Dynamic StudyStatus unknownNCT01459822
• The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUOCompletedNCT01410578
• Comparison the Value of Several Biomarkers of SepsisCompletedNCT01388725
• The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney InjuriesCompletedNCT01333657
• MiRNAs Evaluate the Prognosis of SepsisStatus unknownNCT01207531